Department of Diagnostic and Interventional Radiology, Member of the German Center for Lung Research (DZL), Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Institute for Biostatistics, Hannover Medical School, Hannover, Germany.
Eur J Radiol. 2017 Sep;94:78-84. doi: 10.1016/j.ejrad.2017.06.008. Epub 2017 Jun 15.
To describe early signs for restrictive subtype of chronic lung allograft dysfunction (CLAD) after lung transplantation in computed tomography (CT) and to evaluate the predictive value for disease progression and survival.
52 CT examinations in lung transplant patients at CLAD onset were scored for CT features referring to airways disease, parenchymal or pleural abnormality. Patients with and without later development of restrictive CLAD (TLC≤80%) were compared. A radiological score for inflammation including pleural effusion, central and peripheral ground glass opacities and consolidations was calculated and used for survival analysis.
CT of patients with later development of restrictive CLAD showed significantly more often abnormalities at CLAD onset, in particular consolidations (57% vs. 4%; p<0.001) and ground glass attenuations (71% vs. 7%; p<0.001) than those of patients without the restrictive phenotype. CT score for inflammation was significantly higher in patients with than without later restrictive CLAD (3.4 vs. 0.6; p<0.001). Survival of patients with a high score (>2) for inflammation in CT at CLAD onset was significantly lower than of those with a low score (443 vs. 2415 days; p=0.019).
CT at CLAD onset differs in patients with/without later development of the restrictive phenotype. It is therefore an indicator for future development of restrictive CLAD and predictor for survival. It should be implemented in the diagnostic work-up at diagnosis of CLAD.
描述肺移植后慢性移植物肺功能障碍(CLAD)限制性亚型的早期 CT 征象,并评估其对疾病进展和生存的预测价值。
对 52 例 CLAD 发病时的肺移植患者 CT 进行评分,以评估气道疾病、实质或胸膜异常的 CT 特征。比较有和无限制性 CLAD(TLC≤80%)的患者。计算包括胸腔积液、中央和外周磨玻璃影和实变在内的炎症放射学评分,并用于生存分析。
进展为限制性 CLAD 的患者 CT 显示,在 CLAD 发病时更常出现异常,特别是实变(57%比4%;p<0.001)和磨玻璃衰减(71%比7%;p<0.001),而非限制性表型的患者。有和无限制性 CLAD 患者 CT 炎症评分差异显著(3.4 比 0.6;p<0.001)。CLAD 发病时 CT 炎症评分高(>2)的患者生存率明显低于评分低的患者(443 比 2415 天;p=0.019)。
CLAD 发病时的 CT 在有/无限制性表型的患者中存在差异。因此,它是未来发生限制性 CLAD 的指标和生存的预测因素。它应在 CLAD 诊断时的诊断工作中实施。